In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is quickly establishing itself as a major player, ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

Ozempic in particular led Jeremy Clarkson to have some pretty horrible sickness, while others have noticed changes in their muscle strength, face structure and even in their downstairs area after ...

Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required ...

Whether identifying as Republicans or Democrats, about 70% of adults surveyed say health insurers exert too much influence ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

The expert has revealed why the GLP-1 medication could be playing a role in the bedroom and paving the way for divorce in ...

Eli Lilly and Company’s LLY stock has declined 15.7% in the past year. The first-quarter earnings miss, guidance cut and some ...

The side effects of eating more than the small amount would lead him to become so bloated that he would burp twice every three minutes for hours, and they would smell like sulphur.

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...